Weighing the evidence for pediatric antipsychotic use

Psychiatric Services

Volumn 61, Issue 3, 2010, Pages 325-

  Pathak, Prathamesh ^a   West, Donna ^a   Martin, Bradley C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

CLINICAL DECISION MAKING; CLINICAL STUDY; DRUG SAFETY; EVIDENCE BASED PRACTICE; FOOD AND DRUG ADMINISTRATION; HUMAN; INFORMATION; INTERVIEW; LETTER; MEDICAL RECORD; MONITORING; PEDIATRICS; PHYSICIAN; POPULATION; PRESCRIPTION; RISK BENEFIT ANALYSIS; TIME;

ANTIPSYCHOTIC AGENTS; CHILD; EVIDENCE-BASED MEDICINE; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77949358841     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.61.3.325     Document Type: Letter

References (5)

1. Zima BT: Weighing scientific evidence: let's keep the blindfold off. Psychiatric Services 61:107, 2010
2. Pathak P, West D, Martin BC, et al: Evidence-based use of second-generation antipsychotics in a state Medicaid pediatric population, 2001-2005. Psychiatric Services 61:123-129, 2010
3. Correll C: Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. Journal of Clinical Psychiatry 69(suppl 4):26-36, 2008
4. Olfson M, Blanco C, Liu L, et al: National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of General Psychiatry 63:679-685, 2006
5. Rani FA, Byrne PJ, Murray ML, et al: Pediatric Atypical Antipsychotic Monitoring Safety (PAMS) study: pilot study in children and adolescents in secondary and tertiary care settings. Drug Safety 32:325-333, 2009